Business Context and Reporting Period
This Form 8-K is filed by OncoGenex Pharmaceuticals, Inc. (noted as "ACHIEVE LIFE SCIENCES, INC." in metadata) on May 7, 2009. The report discloses the issuance of a press release regarding financial results for the quarter ended March 31, 2009.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the attached press release (Exhibit 99.1), which is incorporated by reference but not reproduced in the text of this 8-K.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period. It serves solely as a notification that the quarterly results have been announced via a press release.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or unusual items. The press release referenced in Item 2.02 is explicitly stated as not being "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release) for actual financial figures and operational updates.
- Verify the discrepancy between the metadata company name ("ACHIEVE LIFE SCIENCES, INC.") and the registrant name in the filing ("ONCOGENEX PHARMACEUTICALS, INC.").
- Confirm the specific financial performance for the quarter ended March 31, 2009, as it is not listed in the 8-K body.